Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Cargene Therapeutics

Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld, and is advised by a world-class SAB including Professors Harvey Lodish, Jiahai Shi, Roger Foo and Kosh Ray.

Cargene Therapeutics logo
Website - Coming Soon